Update on Abbott's Ritonavir NEW!

By Jules Levin, Executive Director of NATAP

---

Late Breaker Abstracts

Ritonavir Increases Plasma Levels of Other Protease Inhibitors in Animal Models

Viral Resistance to Ritonavir

Ritonavir + AZT + ddC

CD8 Response to Ritonavir

---

This document was written by Jules Levin, Executive Director of NATAP

Go to the HIV Protease Inhibitor Report Menu

Go to the Protease Inhibitor Menu

Go to the Treatment Menu

Go to the HIVpositive.us Main Menu

39